Parks Associates: Fitbit Leads Fitness Tracker Brand

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Parks Associates: Fitbit Leads Fitness Tracker Brand Adoption

DALLAS, TX--(Marketwired - Aug 29, 2014) - Fitbit is the early leader in the market for digital fitness trackers with nearly 40% of the market, according to new research Parks Associates announced today in advance of the firm's Connected Health Summit: Engaging Consumers , September 4-5 in San Diego, California. The 2Q 2014 survey of more than 5,000 U.S. broadband households found that Fitbit is far ahead of its closest competitors Samsung (14%), Nike+ Sensor (14%), and Nike Fuelband (8%).

"Slightly more than 6% of U.S. broadband households have a digital pedometer or fitness tracker, so this market is still in the early stages of adoption," said Harry Wang , Director, Health & Mobile Product Research, Parks Associates. "Fitbit's early success highlights several key factors for success in this market, including fashionable design, integration with mobile devices, and a variety of model options. At Connected Health Summit , executives from top companies in the wearables space will discuss leading techniques both to drive adoption and keep consumers engaged."

Parks Associates analysts recommend companies can achieve long-term success in the digital fitness tracker industry with the following strategies:

  • Standardize measurements of fitness progress and simplify the fitness management process
  • Enrich the user experience by tracking other elements of healthy living
  • Introduce fitness management and coaching services to deepen user engagement and demonstrate value

Parks Associates digital health research shows:

  • 2% of U.S. broadband households purchased a smart watch in 2013, with another 4% very likely to purchase a smart watch in the next 12 months.
  • Connected trackers will account for 52% of all digital fitness tracker unit sales in 2014 and reach 81% by 2018 (66 million units).

Connected Health Summit features the following sessions highlighting the wearables and fitness trackers market:

  • "Healthy Living, Connected Devices, and Wearables" - AARP, American Heart Association, Lowe's Companies, Inc., Masimo, Playtabase
  • "The Role of Connected Devices in Digital Health" - Ayla Networks, Covidien/Zephyr Technology, iHealth Lab, Qualcomm Life/Continua Health Alliance, Z-Wave Alliance
  • "Moving the Digital Health Market Forward: Consumers Take Charge" - Conversa Health, Doctor on Demand, Healthgrades, iTriage, Jawbone
  • "Incentivizing Behavioral Changes: The Impact of Apps and Big Data" - dacadoo, Consumer Electronics Association, Humetrix, RunKeeper, Verizon Enterprise Solutions

Connected Health Summit keynotes include executives from Optum, Qualcomm Life, Humana Wellness, Walgreens, and Ascension Health. Follow the event on Twitter at @CONN_Health_Smt and #ConnectedHealth2014.

Media are invited to attend. Press passes are available at http://www.parksassociates.com/events/connected-health/media and include online access to event materials. To schedule an interview with a speaker or analyst, contact Holly Sprague at hsprague@gmail.com .

About Connected Health Summit Connected Health Summit: Engaging Consumers analyzes the roles of connected health technologies and innovations in driving changes in consumer behaviors and business models. The event focuses on four areas of consumer health technologies in particular, which all require active consumer participation to be successful: remote health monitoring for accountable care, consumer-centric wellness and fitness solutions, independent living technologies and services, and innovative convenience care models.

The 2014 Connected Health Summit: Engaging Consumers will take place September 4-5 at the Omni Hotel in San Diego, CA. www.connectedhealthsummit.com . Follow the event on Twitter at @CONN_Health_Smt. Subscribe to Parks Associates' digital health newsletter at http://www.parksassociates.com/newsletters_subscribe .

About Parks Associates Parks Associates is an internationally recognized market research and consulting company specializing in emerging consumer technology products and services. Founded in 1986, Parks Associates creates research capital for companies ranging from Fortune 500 to small start-ups through market reports, primary studies, consumer research, custom research, workshops, executive conferences, and annual service subscriptions.

The company's expertise includes digital media and platforms, entertainment and gaming, home networks, Internet and television services, digital health, mobile applications and services, support services, consumer apps, advanced advertising, consumer electronics, energy management, and home control systems and security.

Each year, Parks Associates hosts industry webcasts, the CONNECTIONS™ Conference Series, and Smart Energy Summit: Engaging the Consumer. http://www.parksassociates.com

Holly Sprague Parks Associates 720.987.6614 hsprague@gmail.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 718

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit

Updated Category News Views 314

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 262

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 258

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 216

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 110

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading

Top 5 Most Recently Viewed Articles

Omni-Lite Industries Reports Impressive Fiscal Q3 Results

Updated Category News Views 143

Highlights from Omni-Lite's Third Quarter Fiscal 2025 Outstanding Financial Performance Omni-Lite Industries Canada Inc. (TSXV: OML) recently reported its financial results for the third quarter of fiscal 2025, demonstrating notable growth and resilience. With revenue reaching approximately US$4.0 million, Omni-Lite saw a remarkable year-over-year increase of 7.0%...

Continue Reading
Assessing the Impact of UK Fiscal Policy on Housing Market Trends

Updated Category News Views 200

Understanding the Current UK Housing Market Dynamics The U.K. housing market is currently facing a notable slowdown, primarily driven by tax-related uncertainties associated with fiscal policies. As potential buyers adopt a more cautious stance, residential property transactions have seen a decline. This trend poses immediate risks for sectors linked to housing, including...

Continue Reading
Radford Racing School Unveils New Exciting Driving Adventures

Updated Category News Views 226

Exciting New Driving Experiences at Radford Racing School Recently, Radford Racing School, known as a leader in performance driving education, announced its latest offerings that promise to thrill automotive enthusiasts of all ages and skill levels. With the introduction of six new driving experiences, there's now something for everyone at their legendary racetrack....

Continue Reading
AppLovin CEO Sells $21.5 Million in Shares Amid Growth Momentum

Updated Category News Views 137

AppLovin CEO's Notable Stock Sale Recently, AppLovin Corp (NASDAQ: APP) made headlines with a significant financial event: CEO and Chairperson Arash Adam Foroughi sold over $21.5 million worth of company stock. According to the latest SEC filing, this noteworthy transaction occurred over just two days, with share prices varying from $98.08 to $112.33 during that time....

Continue Reading
Olverembatinib's Breakthrough Status Enhances Leukemia Treatment Options

Updated Category News Views 396

Olverembatinib Gains Breakthrough Therapy Designation Ascentage Pharma, a prominent global biopharmaceutical company, is making significant strides in the treatment of serious medical conditions. With its latest achievement, olverembatinib has secured a Breakthrough Therapy Designation in China for its use alongside low-intensity chemotherapy in newly-diagnosed patients...

Continue Reading